A study evaluating effect of CYP3A4 inducer, Carbamazepine on Pharmacokinetics of BIIB-074 in healthy volunteers.

Trial Profile

A study evaluating effect of CYP3A4 inducer, Carbamazepine on Pharmacokinetics of BIIB-074 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Raxatrigine (Primary) ; Carbamazepine
  • Indications Erythromelalgia; Neuropathic pain; Trigeminal neuralgia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Sep 2017 New trial record
    • 01 Sep 2017 Results published in Clinical Pharmacology in Drug Development: 2017 Annual Meeting of the American College of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top